-transparent.png){kind=logo}
Oncogene analyses of four human myeloma cell lines provided no indication of gene amplification or rearrangement using DNA probes for the met, raf, abl, mos, erb B, Her-2-neu, fos, myb-7, fms, L-myc, sis, and myb-1 genes. However, a consistent elevation of up to 23-fold in the level of c-myc mRNA was observed in all of the cell lines studied. No restriction fragment length polymorphism (in exons one, two, or three) or c-myc gene amplification has as yet been demonstrated to account for the c-myc mRNA elevation. The c-myc mRNA has a half-life of 25 min which is comparable to that observed in other systems. The elevation in c-myc mRNA is further evidence for the role of the c-myc proto-oncogene in the pathogenesis of myeloma.
R Fourney, and
M Palmer, and
A Ng, and
K Dietrich, and
A Belch, and
M Paterson, and
L Brox
January 2008,
Journal of the National Cancer Institute. Monographs,
R Fourney, and
M Palmer, and
A Ng, and
K Dietrich, and
A Belch, and
M Paterson, and
L Brox
April 1992,
International journal of cancer,
R Fourney, and
M Palmer, and
A Ng, and
K Dietrich, and
A Belch, and
M Paterson, and
L Brox
April 1987,
The Journal of experimental medicine,
R Fourney, and
M Palmer, and
A Ng, and
K Dietrich, and
A Belch, and
M Paterson, and
L Brox
January 1997,
Current topics in microbiology and immunology,
R Fourney, and
M Palmer, and
A Ng, and
K Dietrich, and
A Belch, and
M Paterson, and
L Brox
January 1997,
Current topics in microbiology and immunology,
R Fourney, and
M Palmer, and
A Ng, and
K Dietrich, and
A Belch, and
M Paterson, and
L Brox
May 2016,
Blood,
R Fourney, and
M Palmer, and
A Ng, and
K Dietrich, and
A Belch, and
M Paterson, and
L Brox
September 2012,
Blood,
R Fourney, and
M Palmer, and
A Ng, and
K Dietrich, and
A Belch, and
M Paterson, and
L Brox
October 1996,
Cancer research,
R Fourney, and
M Palmer, and
A Ng, and
K Dietrich, and
A Belch, and
M Paterson, and
L Brox
September 2015,
Oncotarget,
R Fourney, and
M Palmer, and
A Ng, and
K Dietrich, and
A Belch, and
M Paterson, and
L Brox
February 1991,
British journal of haematology,
